Skip to content

Metabolic Risk Wearable Verification Data Collection

Metabolic Risk Wearable Verification Data Collection

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0009784
Enrollment
350
Registered
2024-09-11
Start date
2024-08-26
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

P&K Skin Research Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. adults aged 20 to 69 2. BMI of 20 to 44 years of age 25 or older, or 45 years of age or older 3. A person who has no history of diabetes diagnosis in a preliminary survey 4. A person who voluntarily prepares and signs a consent form after hearing a sufficient explanation of matters to be notified to the test subject from the person in charge of testing or a person entrusted by the test manager 5. a healthy person who has no acute, chronic physical condition, including infectious skin disease 6. A person who can follow up during the test period * Must be kept on an empty stomach for more than 8 hours

Exclusion criteria

Exclusion criteria: 1. Women who are pregnant or lactating and women who are likely to become pregnant 2. If you don't want it or you don't fill out the consent form 3. If you have a psychiatric disorder 4. If immunosuppressant treatment is received within 3 months of participation in the trial 5. If you received systemic steroid or light therapy within one month of participation in the trial 6. If there is a lesion at the test site and it is difficult to measure it 7. If you have atopic skin 8. If the reaction to cosmetics, medicines, or daily exposure to light is severe or allergic 9. If you have received skin scheduling and skin care within 3 months of participation in the test 10. In addition to the above matters, if it is deemed difficult to conduct human testing at the judgment of the lead researcher or the person in charge of testing

Design outcomes

Primary

MeasureTime frame
Skin fluorescence value

Secondary

MeasureTime frame
a blood chemistry examination;Blood pressure;body composition analyzer;Waist-hip ratio ;ECG, PPG

Countries

Korea, Republic of

Contacts

Public ContactEUN JI LIM

P&K Skin Research Center

ej.lim2@pnkskin.com+82-2-6925-1501

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026